miércoles, 12 de diciembre de 2012

Reputación de la Industria farmacéutica (debil) sube...excepto en China.

Key findings:

  • • While favorable at a global level, the image of the pharmaceutical industry is weak, if not clearly negative in many key markets, including the U.S., Canada, China, Germany, and Spain.
  • • Negative industry perceptions by consumers are often accompanied by the desire for more regulation, which is particularly strong in France, Russia, and China.
  • • Attitudes toward leading companies do not always reflect attitudes toward the industry. In the U.S. and China, leading global pharmaceutical companies have succeeded in establishing an image that rises above that of the overall industry. However, this is not the case in many countries, especially in Sweden, France, Italy, and Korea.
  • • Leading pharmaceutical companies tend to be better perceived when it comes to the quality of their products and their industry leadership than on being good citizens.
  • • Globally, consumers are fairly unanimous in singling out what pharmaceutical companies can do to better demonstrate their corporate citizenship: develop innovative drugs to fight diseases, ensure the safety of drugs produced in other countries, and develop assistance programs that provide less expensive drugs to low-income families.

Se puede
Publicar un comentario